First reports of serious adverse drug reactions in recent weeks

In this: publication
By this: publisher
In this Subject: Pharmacology
By this author: Adis International Limited,

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 3, March 2009 , pp. 25-26(2)

Buy & download fulltext article:

Price: $32.95 plus tax (Refund Policy)

Abstract:

The following table contains an overview of first published case reports of serious adverse drug reactions (ADRs) identified in the international literature in recent weeks by the drug safety alerting service Reactions Weekly. An event is serious (FDA MedWatch definition) when the patient outcome is death, life-threatening, hospitalization, disability, congenital anomaly or requires intervention to prevent permanent impairment or damage. Reactions and the customized Reactions Pharmacovigilance Service are produced by Wolters Kluwer Health | Adis and monitor >4000 journals, including relevant MEDLINE- and EMBASE-indexed journals, as well as companion journal supplements, major scientific meetings, the newsletters from the >80 national centres participating in the WHO International Drug Monitoring Programme, media releases, pharmaceutical company websites, and regulatory agency websites.

Keywords: Adverse drug reactions

Document Type: Research article

Publication date: 2009-03-01